122
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Association between polymorphisms in transforming growth factor-β1 and sporadic Alzheimer's disease in a Chinese population

, , &
Pages 979-984 | Received 19 Apr 2015, Accepted 27 Aug 2015, Published online: 22 Sep 2015

References

  • Sayad A, Noruzinia M, Zamani M, et al. Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease. Demen Geriatr Cogn Disord 2014;37:257–64.
  • Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094–9.
  • Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009;41:1088–93.
  • Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011;43:429–35.
  • Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 2011;68:320–8.
  • Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. Jama 2010;303:1832–40.
  • Lim YY, Ellis KA, Ames D, et al. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimers Demen 2013;9:538–45.
  • Caraci F, Spampinato S, Sortino MA, et al. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res 2012;347:291–301.
  • Hamaguchi T, Okino S, Sodeyama N, et al. Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 2005;76:696–9.
  • Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 2006;24:99–146.
  • ** ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004;29:265–73.
  • Caraci F, Battaglia G, Busceti C, et al. TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis 2008;30:234–42.
  • Araria-Goumidi L, Lambert JC, Mann DM, et al. Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;73:62–4.
  • Arosio B, Bergamaschini L, Galimberti L, et al. +10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution. Mech Ageing Dev 2007;128:553–7.
  • Caraci F, Bosco P, Signorelli M, et al. The CC genotype of transforming growth factor-beta1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol 2012;22:281–9.
  • Dickson MR, Perry RT, Wiener H, et al. Association studies of transforming growth factor-beta 1 and Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2005;139:38–41.
  • Luedecking EK, DeKosky ST, Mehdi H, et al. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 2000;106:565–9.
  • Peila R, Yucesoy B, White LR, et al. A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS. Neurobiol Aging 2007;28:1367–73.
  • Ribizzi G, Fiordoro S, Barocci S, et al. Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol Sci 2010;31:321–5.
  • Rodriguez-Rodriguez E, Sanchez-Juan P, Mateo I, et al. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease. Acta Neurol Scand 2007;116:409–12.
  • Shawkatova I, Javor J, Parnicka Z, et al. No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks. Acta Neurobiol Exp (Wars) 2010;70:303–7.
  • van Oijen M, Arp PP, de Jong FJ, et al. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 2006;402:113–7.
  • Salins P, He Y, Olson K, et al. TGF-beta1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis. Neurosci Lett 2008;430:81–6.
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–9.
  • Katzman R, Zhang, Ouang-Ya-Qu MY,, et al. A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol 1988;41:971–8.
  • Mormino EC, Betensky RA, Hedden T, et al. Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 2014;82:1760–7.
  • Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149–50.
  • Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137–61.
  • Lahiri DK, Ge YW, Maloney B. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. Faseb J 2005;19:653–5.
  • Cacquevel M, Lebeurrier N, Cheenne S, et al. Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 2004;5:529–34.
  • Mousseau DD, Chapelsky S, De Crescenzo G, et al. A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner. J Biol Chem 2003;278:38715–22.
  • Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014–20.
  • Hutchinson I, Turner D, Sankaran D, et al. Influence of cytokine genotypes on allograft rejection. Transplant Proc 1998;30:862–3.
  • Perrey C, Turner SJ, Pravica V, et al. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999;7:127–8.
  • Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93–7.
  • Wood NA, Thomson SC, Smith RM, et al. Identification of human TGF-beta1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 2000;234:117–22.
  • Chang WW, Zhang L, Jin YL, et al. Meta-analysis of the transforming growth factor-beta1 polymorphisms and susceptibility to Alzheimer's disease. J Neural Transm 2013;120:353–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.